Nutrition / Minerals

Iron: Comprehensive Guide to Testing, Deficiency, and Optimization

Creator: Dr. Joshua Lindsley
Published: 2026-03-23

Dr. Joshua Lindsley, DO | Last Updated: January 2026 | 19 min read

Key Takeaways

Iron deficiency is the most common nutritional deficiency worldwide, affecting 2–3 billion people — and symptoms often appear long before anemia develops
Ferritin below 50 ng/mL commonly causes fatigue, brain fog, and exercise intolerance, even when hemoglobin is “normal”
A complete iron panel (ferritin, serum iron, TIBC, transferrin saturation) is essential — ferritin alone is insufficient, especially with inflammation
Alternate-day dosing of oral iron may be as effective as daily dosing with fewer side effects due to hepcidin dynamics
Hereditary hemochromatosis must be excluded before supplementation — it affects 1 in 200–300 people of Northern European descent and makes iron supplementation dangerous

Summary

Iron represents one of the most fundamentally important minerals for human health, with approximately 2% of the human genome dedicated to encoding proteins involved in iron metabolism. This remarkable genetic investment reflects iron’s essential role in oxygen transport, energy production, DNA synthesis, and countless enzymatic reactions throughout the body. Despite its critical importance, iron deficiency remains the most common nutritional deficiency worldwide, affecting an estimated 2–3 billion people and representing a frequently overlooked cause of fatigue, cognitive impairment, and diminished quality of life.

The distinction between iron deficiency and iron deficiency anemia represents a crucial clinical concept that is often misunderstood. Iron deficiency — the depletion of iron stores — can produce significant symptoms long before anemia develops. Many individuals suffer from fatigue, brain fog, restless legs, cold intolerance, and exercise intolerance while being told their labs are “normal” because hemoglobin levels remain within reference ranges. Understanding the full spectrum of iron status testing, including ferritin, transferrin saturation, and total iron-binding capacity, enables earlier detection and intervention.

Iron metabolism involves a sophisticated homeostatic system with no active excretion mechanism. The body can only regulate iron through controlling absorption, making both deficiency and overload states clinically significant. While this guide focuses primarily on deficiency, awareness of hereditary hemochromatosis — a common genetic condition causing iron overload — remains essential, as supplementation in affected individuals can cause serious harm. The approach to iron optimization requires individualized assessment, appropriate testing, and targeted intervention strategies.

The Fundamental Importance of Iron

Biological Functions

Function	Description	Clinical Relevance
Oxygen Transport	Hemoglobin carries oxygen from lungs to tissues	Anemia causes fatigue, dyspnea
Oxygen Storage	Myoglobin stores oxygen in muscle	Exercise intolerance
Energy Production	Cytochromes in electron transport chain	Fatigue, weakness
DNA Synthesis	Ribonucleotide reductase requires iron	Cell division impairment
Neurotransmitter Synthesis	Dopamine, serotonin production	Cognitive issues, mood changes
Collagen Production	Hydroxylation enzymes need iron	Connective tissue health
Immune Function	Multiple immune cell processes	Infection susceptibility
Thyroid Hormone Production	Thyroid peroxidase requires iron	Metabolic dysfunction

The Bottom Line

Iron deficiency represents a vastly under-recognized contributor to fatigue, cognitive dysfunction, exercise intolerance, and diminished quality of life. The conventional approach of waiting until frank anemia develops before intervening fails countless individuals whose iron stores are depleted but hemoglobin remains technically “normal.”

Understanding that symptoms commonly occur at ferritin levels below 50 ng/mL — well within standard “reference ranges” — enables earlier intervention and faster resolution of symptoms. Testing should include a complete iron panel (ferritin, serum iron, TIBC, transferrin saturation) rather than ferritin alone, and results must be interpreted in clinical context, particularly considering inflammatory states that can falsely elevate ferritin.

For those with confirmed deficiency, oral supplementation using alternate-day dosing, formulations with vitamin C, or liquid preparations often provides adequate repletion with minimized side effects. However, IV iron should be considered early when oral therapy fails, when malabsorption is present, or when restless legs syndrome proves refractory to oral iron.

Critically, before initiating any iron supplementation, hereditary hemochromatosis must be excluded through appropriate testing — this common genetic condition makes supplementation dangerous, and the early symptoms of both deficiency and overload paradoxically overlap. Individualized assessment, comprehensive testing, and targeted intervention form the foundation of rational iron optimization.

Continue Reading This Evidence-Based Guide

Free access to 235+ health education guides from Highland Longevity

No spam. Unsubscribe anytime.

Iron Distribution in the Body

Compartment	Percentage	Amount (mg)	Primary Form
Hemoglobin	65–70%	2,000–2,500	Functional iron
Storage (liver, spleen, bone marrow)	20–25%	500–1,000	Ferritin, hemosiderin
Myoglobin	3–5%	100–200	Functional iron
Enzymes and other proteins	1–2%	50–100	Various forms
Transport (transferrin)	<1%	3–4	Transferrin-bound

Iron Metabolism and Homeostasis

Absorption Mechanisms

Iron absorption occurs primarily in the duodenum and upper jejunum through two distinct pathways depending on iron form:

Iron Form	Absorption Pathway	Absorption Rate	Dietary Sources
Heme Iron	Direct transport via HCP1	15–35%	Meat, poultry, fish
Non-Heme Iron	DMT1 transporter after reduction	2–20%	Plants, fortified foods, supplements

Factors Affecting Iron Absorption

Enhancers	Inhibitors
Vitamin C (ascorbic acid)	Phytates (grains, legumes)
Meat/fish/poultry factor	Polyphenols (tea, coffee)
Gastric acid	Calcium (when consumed together)
Iron deficiency state	Antacids/PPIs
Fermented foods	Oxalates
Low iron stores	High iron stores

The Hepcidin-Ferroportin System

Hepcidin, produced by the liver, serves as the master regulator of iron homeostasis:

State	Hepcidin Level	Ferroportin Activity	Net Effect
Iron deficiency	Low	High	Increased absorption
Iron overload	High	Low	Decreased absorption
Inflammation/infection	High	Low	Iron sequestration
Hypoxia	Low	High	Increased availability
Erythropoiesis demand	Low	High	Mobilization for RBC production

Comprehensive Iron Testing

Essential Tests and Interpretation

Test	What It Measures	Optimal Range	Notes
Ferritin	Iron storage protein	50–150 ng/mL (women), 75–200 ng/mL (men)	Can be falsely elevated with inflammation
Serum Iron	Circulating iron	60–170 mcg/dL	High diurnal variation; limited utility alone
TIBC	Total iron-binding capacity	250–370 mcg/dL	Indirect measure of transferrin
UIBC	Unsaturated iron-binding capacity	110–370 mcg/dL	TIBC minus serum iron
Transferrin Saturation	% of transferrin bound to iron	20–45%	Calculated: (Serum Iron/TIBC) × 100
Hemoglobin	Oxygen-carrying protein	12–16 g/dL (women), 14–18 g/dL (men)	Late marker of iron deficiency
MCV	Mean corpuscular volume	80–100 fL	Decreased in established iron deficiency
RDW	Red cell distribution width	11.5–14.5%	Elevated early in iron deficiency
Reticulocyte Hemoglobin	Hemoglobin in new RBCs	>28 pg	Early functional iron marker
Soluble Transferrin Receptor	Membrane receptor fragment	Varies by assay	Elevated in true deficiency; not affected by inflammation

Interpreting Results in Context

Pattern	Ferritin	Transferrin Sat	TIBC	Interpretation
Iron deficiency	Low (<30)	Low (<20%)	High	Classic deficiency pattern
Iron deficiency anemia	Very low (<15)	Very low (<15%)	High	Advanced deficiency
Anemia of chronic disease	Normal/High	Low/Normal	Low/Normal	Inflammation-mediated
Iron overload	High (>300)	High (>45%)	Low	Hemochromatosis or iatrogenic
Functional iron deficiency	Normal	Low	Normal	Inadequate mobilization

The Ferritin Controversy

Ferritin interpretation remains controversial because:

Reference ranges are population-based, not optimal: Standard “normal” ranges (12–150 ng/mL for women) include many symptomatic individuals
Ferritin is an acute phase reactant: Inflammation can double or triple ferritin independent of iron stores
Symptoms occur at “normal” levels: Many individuals experience resolution of symptoms when ferritin increases from 30 to 100+ ng/mL
Gender differences: Pre-menopausal women have chronically lower ferritin due to menstrual losses

Ferritin Level	Clinical Interpretation
<15 ng/mL	Definite iron depletion
15–30 ng/mL	Probable deficiency; symptoms likely
30–50 ng/mL	Possible sub-optimal; consider symptoms
50–150 ng/mL	Generally adequate for most individuals
150–300 ng/mL	Upper adequate range; rule out inflammation
>300 ng/mL	Evaluate for overload or inflammation

Iron Deficiency: Beyond Anemia

Stages of Iron Deficiency

Stage	Iron Stores	Serum Iron	Hemoglobin	Symptoms
1: Depletion	Reduced	Normal	Normal	Often subtle or absent
2: Iron-deficient erythropoiesis	Depleted	Reduced	Normal	Fatigue, cognitive changes
3: Iron deficiency anemia	Depleted	Low	Reduced	Pronounced symptoms

Symptoms of Iron Deficiency (Even Without Anemia)

System	Symptoms
Neurological	Fatigue, brain fog, poor concentration, headaches
Muscular	Weakness, exercise intolerance, prolonged recovery
Thermoregulation	Cold intolerance, cold hands/feet
Dermatological	Hair loss, brittle nails, pale skin
Cardiovascular	Palpitations, dyspnea on exertion
Neurological-Motor	Restless legs syndrome
Immune	Frequent infections
Psychological	Irritability, depression, anxiety

Restless Legs Syndrome and Iron

The connection between iron deficiency and restless legs syndrome (RLS) is particularly strong:

Finding	Clinical Implication
Brain iron often low even with normal serum ferritin	CSF ferritin may be more relevant
Symptoms correlate with ferritin <50–75 ng/mL	Higher threshold than for anemia
IV iron often more effective than oral	Crosses blood-brain barrier more effectively
Dopamine synthesis requires iron	Explains motor symptoms
RLS may resolve completely with iron repletion	First-line intervention before medications

Prevalence and Risk Factors

Who Is at Risk?

Population	Risk Level	Primary Mechanisms
Pre-menopausal women	High	Menstrual blood loss
Pregnant women	Very high	Expanded blood volume, fetal needs
Athletes (especially female)	High	Foot-strike hemolysis, sweat losses, GI bleeding
Vegetarians/vegans	Moderate–High	Lower absorption from plant sources
Frequent blood donors	Moderate–High	Direct blood loss
Elderly	Moderate	Reduced absorption, chronic disease
Individuals with GI disorders	High	Malabsorption (celiac, IBD, H. pylori)
Post-bariatric surgery	Very high	Bypassed absorption sites
Chronic NSAID users	Moderate	GI blood loss
Heavy tea/coffee consumers	Moderate	Absorption inhibition

Gender-Specific Considerations

Factor	Women	Men
Prevalence of deficiency	10–15% (pre-menopausal)	2–3%
Menstrual losses	30–40 mg/month average	N/A
Pregnancy requirements	+700–1,000 mg total	N/A
Post-menopausal status	Risk equalizes with men	Risk increases with age
Hemochromatosis expression	Often masked by menses	More likely symptomatic

Dietary Iron Sources

Heme vs Non-Heme Iron Content

Food	Iron (mg per serving)	Type	Bioavailability
Beef liver (3 oz)	5.0	Heme	High
Oysters (3 oz)	8.0	Heme	High
Beef (3 oz)	2.5–3.0	Heme	High
Chicken thigh (3 oz)	1.1	Heme	High
Clams (3 oz)	23.0	Heme	High
Spinach (1 cup cooked)	6.4	Non-heme	Low
Lentils (1 cup)	6.6	Non-heme	Low
Fortified cereals	4.5–18.0	Non-heme	Moderate
Tofu (1/2 cup)	3.4	Non-heme	Low
Pumpkin seeds (1 oz)	2.3	Non-heme	Low

Maximizing Dietary Iron Absorption

Strategy	Rationale
Pair plant iron with vitamin C	Reduces ferric to ferrous iron
Cook in cast iron	Increases iron content of acidic foods
Separate calcium from iron meals	Avoid competition for absorption
Limit tea/coffee with meals	Reduce polyphenol inhibition
Include some heme iron	Enhances non-heme absorption
Address H. pylori if present	Restores gastric acid production
Consider gastric acid status	PPIs significantly reduce absorption

Iron Supplementation

Oral Iron Options

Formulation	Elemental Iron	Absorption	GI Tolerance	Notes
Ferrous sulfate	65 mg per 325 mg tablet	Good	Poor	Most studied; cheapest
Ferrous gluconate	35 mg per 325 mg tablet	Good	Better	Lower dose per tablet
Ferrous fumarate	106 mg per 325 mg tablet	Good	Moderate	Highest elemental iron
Slow Fe (slow-release)	45 mg per tablet	Moderate	Good	Carbonyl iron matrix
Vitron-C	65 mg + vitamin C	Enhanced	Fair	Built-in absorption enhancer
Floradix	~10 mg per serving	Good	Excellent	Liquid; herbal formulation
Iron bisglycinate	Varies	Excellent	Good	Chelated; less GI effects
Polysaccharide iron complex	150 mg per capsule	Moderate	Good	Non-ionic; ferritin-like

Dosing Strategies

Approach	Protocol	Rationale
Traditional high-dose	65 mg elemental 2–3x daily	Maximizes total absorption
Alternate-day dosing	65 mg every other day	Reduces hepcidin spike; similar efficacy
Low-dose daily	15–30 mg daily	May be equally effective with fewer side effects
Single morning dose	65 mg AM on empty stomach	Absorption highest with low hepcidin
With vitamin C	200–500 mg vitamin C with iron	2–3 fold increase in absorption

Managing Side Effects

Side Effect	Strategies
Constipation	Add magnesium; increase fluids/fiber; use alternate-day dosing
Nausea	Take with small amount of food; try different formulation
Stomach upset	Start low, increase gradually; try liquid forms
Metallic taste	Try different formulation; take with juice
Dark stools	Expected and harmless; distinguish from GI bleeding

Intravenous Iron Therapy

When to Consider IV Iron

Indication	Rationale
Oral iron intolerance despite multiple formulations	Bypasses GI tract
Malabsorption conditions	Direct delivery to bloodstream
Need for rapid repletion	Faster than oral
Ongoing losses exceeding oral replacement	Can’t keep up with losses
Restless legs syndrome unresponsive to oral iron	Better CNS penetration
Inflammatory states with functional deficiency	Bypasses hepcidin block
Post-bariatric surgery	Bypassed absorption sites

IV Iron Formulations

Formulation	Dose Range	Infusion Time	Anaphylaxis Risk	Notes
Iron sucrose (Venofer)	200–300 mg	15–60 min	Low	Most widely used; multiple doses needed
Ferric gluconate (Ferrlecit)	125 mg	10 min	Low	Dialysis populations
Ferric carboxymaltose (Injectafer)	750 mg × 2	15–30 min	Very low	Can give 1,500 mg total
Ferumoxytol (Feraheme)	510 mg × 2	15–60 min	Moderate	Black box warning
Iron isomaltoside (Monoferric)	Up to 1,500 mg	15–60 min	Very low	Single high-dose option

Monitoring After IV Iron

Parameter	Timeline	Expected Change
Ferritin	2–4 weeks	May temporarily spike very high
Transferrin saturation	1–2 weeks	Normalizes before ferritin
Hemoglobin	4–8 weeks	Gradual increase
Symptoms	1–4 weeks	Often improve before labs
Reticulocyte count	3–7 days	Increases with effective response

Hemochromatosis: The Critical Counterpoint

Overview

Hereditary hemochromatosis is among the most common genetic disorders in populations of Northern European descent:

Aspect	Details
Prevalence	1 in 200–300 (homozygous HFE mutation)
Inheritance	Autosomal recessive (C282Y mutation most common)
Mechanism	Inappropriately low hepcidin → unregulated iron absorption
Onset of symptoms	Typically 40–60 years (men); post-menopausal (women)

Warning Signs of Iron Overload

System	Manifestations
Liver	Elevated enzymes, cirrhosis, hepatocellular carcinoma
Heart	Cardiomyopathy, arrhythmias, heart failure
Pancreas	Diabetes (“bronze diabetes”)
Joints	Arthritis (especially 2nd/3rd MCP joints)
Endocrine	Hypogonadism, hypothyroidism
Skin	Bronze discoloration, hyperpigmentation
General	Fatigue (paradoxically similar to deficiency)

Screening and Diagnosis

Test	Threshold for Concern	Action
Ferritin >300 ng/mL (men) or >200 ng/mL (women)	Evaluate further	Rule out inflammation; repeat fasting
Transferrin saturation >45%	High sensitivity screening	Genetic testing indicated
Fasting transferrin saturation >55%	Highly suggestive	Confirm with genetic testing
Positive HFE genetic test	Diagnostic	Assess organ involvement
Liver iron by MRI	Quantifies hepatic iron	Guides phlebotomy frequency

Why This Matters for Supplementation

Supplementing someone with undiagnosed hemochromatosis can accelerate organ damage. Always check iron studies before chronic supplementation. Symptoms of deficiency and overload overlap — fatigue alone is insufficient for empiric treatment. Screen first-degree relatives of affected individuals.

Special Considerations

Athletes and Iron

Factor	Impact	Management
Foot-strike hemolysis	RBC destruction with running	Higher ferritin targets (>50)
GI blood loss	Common with intense exercise	Monitor ferritin; consider GI evaluation
Sweat losses	Small but additive	Adequate dietary intake
Dilutional pseudoanemia	Plasma volume expansion	Interpret with caution
Higher ferritin targets	Many perform better at 50–100	Individualize based on response

Pregnancy

Trimester	Considerations
Pre-conception	Optimize ferritin >50 before pregnancy
First trimester	Ferritin often drops; morning sickness limits intake
Second–third trimester	Expanded blood volume; fetal needs peak
Postpartum	Blood loss at delivery; replete aggressively
Lactation	Ongoing increased requirements

Vegetarians and Vegans

Challenge	Strategy
Lower bioavailability	Pair plant iron with vitamin C
Higher intake requirements	Need ~1.8× omnivore intake
Phytates in whole grains/legumes	Soaking, sprouting, fermentation reduce phytates
Absorption inhibitors common	Strategic meal timing
Supplement consideration	Often necessary for menstruating women

Practical Approach to Iron Optimization

When to Test

Scenario	Recommended Testing
Unexplained fatigue	Full iron panel + CBC
Restless legs syndrome	Ferritin minimum; full panel preferred
Heavy menstrual periods	Annual screening
Vegetarian/vegan diet	Annual screening
Athletic performance plateau	Full iron panel
Planning pregnancy	Pre-conception screening
Post-bariatric surgery	Every 3–6 months initially
New anemia discovered	Full workup including iron

Repletion Timeline Expectations

Method	Time to Normalize Hemoglobin	Time to Replete Stores
Dietary alone (mild deficiency)	3–6 months	6–12 months
Oral supplementation	2–4 months	3–6 months
IV iron	4–8 weeks	Immediate (stores)

Monitoring During Repletion

Phase	Testing Frequency	Target
Initial (first month)	Reticulocyte count at 1–2 weeks	Response confirmation
Active repletion	CBC, ferritin monthly	Hemoglobin, ferritin trending up
Maintenance	Every 3–6 months	Ferritin 50–150 stable
Post-repletion	Every 6–12 months	Ensure no recurrence

Key Studies & Data

Finding	Result	Significance
Ferritin symptom threshold	Symptoms common below 50 ng/mL	Below standard “normal” range
Alternate-day dosing	Better absorption than daily	Hepcidin dynamics favor spacing
Hemochromatosis prevalence	1 in 200–300 Caucasians	Must rule out before supplementation
RLS ferritin target	>75 ng/mL often needed	Higher than general deficiency targets
Athlete iron needs	70% higher due to losses	Routine testing recommended
IV iron efficacy	Faster repletion than oral	Preferred for severe deficiency or malabsorption

Additional Considerations

Study Limitations

Ferritin cutoffs: Optimal ferritin ranges (50–150 ng/mL) are based on expert opinion and symptom response rather than long-term outcome data.
Restless legs syndrome studies: Iron infusion trials often small with variable endpoints; optimal ferritin target debated.
Athlete studies: Many conducted in elite athletes; findings may not generalize to recreational exercisers.
Hemochromatosis screening: Not universally recommended; cost-effectiveness debated among screening bodies.

Conflicting Evidence

Ferritin targets: Some experts advocate for higher targets (>100 ng/mL) while others consider 30–50 ng/mL adequate for most individuals.
Oral vs IV iron timing: When to escalate from oral to IV therapy varies among practitioners; no consensus threshold.
Alternate-day dosing: While evidence supports better absorption, some cases require daily dosing for faster repletion.
Heme vs non-heme iron: Health implications of heme iron remain debated; some associate it with cardiovascular risk.

Safety Notes

Hemochromatosis exclusion: CRITICAL — must exclude hereditary hemochromatosis before supplementation; early symptoms overlap with deficiency.
GI side effects: Constipation, nausea common with oral iron; alternate-day dosing and formulation changes may help.
IV iron risks: Anaphylaxis rare but possible; infusion should occur in monitored settings with resuscitation capability.
Iron and infection: Some evidence suggests iron can promote bacterial growth; avoid supplementation during acute infection.

Recent Developments

Hepcidin testing: Emerging marker may help identify those who will respond to oral vs IV iron.
New oral formulations: Sucrosomial iron and other advanced formulations show promise for better absorption with fewer side effects.
Restless legs research: Growing recognition that many “treatment-resistant” cases have inadequate iron repletion.

References

Camaschella, C. (2015). Iron-deficiency anemia. New England Journal of Medicine, 372(19), 1832–1843.
Lopez, A., Cacoub, P., Macdougall, I. C., & Peyrin-Biroulet, L. (2016). Iron deficiency anaemia. The Lancet, 387(10021), 907–916.
Stoffel, N. U., et al. (2017). Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women. The Lancet Haematology, 4(11), e524–e533.

Medical Disclaimer: This educational brief is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before starting any new health regimen. Individual results may vary. The information presented reflects current research as of January 2026 and may be updated as new evidence becomes available.